全球急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

全球急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗市场预测将大幅成长，市场规模预计到 2033 年将飙升至 27.3 亿美元，较 2024 年的 17.1 亿美元大幅成长。这一扩张反映了 2025 年至 2033 年期间预计的 5.32% 的惊人年复合成长率(CAGR)。

受细菌感染发生率上升和抗生素抗药性挑战加剧的推动，ABSSSI 治疗市场有望实现成长。包括脂糖肽、噁唑烷酮和 β-内酰胺酶抑制剂在内的新型抗菌药物正在扩大治疗选择，并提高疗效和安全性。未来的发展将着重于标靶治疗、联合方案和快速诊断工具，以优化治疗效果并减少住院时间。

此外，抗菌药物管理计画与个人化医疗方法的整合正在增强临床决策。糖尿病和肥胖等合併症的日益流行，增加了患者的易感性，推动了对有效ABSSSI治疗的需求。药物输送系统（包括外用和长效製剂）的进步正在提高患者的依从性。随着医疗保健系统不断对抗抗药性病原体，ABSSSI治疗市场将继续创新，提供先进的疗法来满足尚未满足的临床需求。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按感染类型分析市场吸引力
  • 按药品类别分析市场吸引力
  • 按给药途径进行的市场吸引力分析
  • 按配销通路分析市场吸引力
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球急性细菌性皮肤和皮肤结构感染（ABSSSI）治疗市场分析：依感染类型

• 按感染类型概述
• 按感染类型分析历史和预测数据
• 社区型 ABSSSI
• 医院获得性ABSSSI

第六章：全球急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗市场分析：按药物类别

• 按药物类别概述
• 按药物类别进行的历史和预测数据分析
• 醣肽/脂糖肽
• 噁唑烷酮类
• β-内酰胺类
• 脂肽
• 四环素类
• 其他药物类别

第七章：全球急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗市场分析：按给药途径

• 依给药途径概述
• 按给药途径进行的历史和预测数据分析
• 肠外
• 口服
• 外用

第 8 章：全球急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗市场分析：按分销管道

• 按配销通路概览
• 按配销通路进行历史和预测资料分析
• 医院药房
• 零售药局
• 网路药局

第九章：全球急性细菌性皮肤和皮肤结构感染（ABSSSI）治疗市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 10 章：急性细菌性皮肤和皮肤结构感染 (ABSSSI) 治疗公司的竞争格局

• 急性细菌性皮肤和皮肤结构感染（ABSSSI）治疗市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• AbbVie
• 公司概况
• 公司收入
• 产品
• 最新动态
• Basilea Pharmaceutica
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cipher Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Endo Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Glenmark Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Melinta Therapeutics
• 公司概况
• 公司收入
• 产品
• 最新动态
• Menarini Group
• 公司概况
• 公司收入
• 产品
• 最新动态
• Merck
• 公司概况
• 公司收入
• 产品
• 最新动态
• Nabriva Therapeutics
• 公司概况
• 公司收入
• 产品
• 最新动态
• Paratek Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Pfizer
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sandoz
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

The forecast for the Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment market predicts substantial growth, with market size projected to soar to USD 2.73 Billion by 2033, a significant increase from the USD 1.71 Billion recorded in 2024. This expansion reflects an impressive compound annual growth rate (CAGR) of 5.32% anticipated between 2025 and 2033.

The ABSSSI treatment market is poised for growth driven by rising incidence of bacterial infections and increasing antibiotic resistance challenges. Novel antimicrobial agents, including lipoglycopeptides, oxazolidinones, and beta-lactamase inhibitors, are expanding therapeutic options with improved efficacy and safety profiles. Future developments will focus on targeted therapies, combination regimens, and rapid diagnostic tools to optimize treatment outcomes and reduce hospital stays.

Moreover, the integration of antimicrobial stewardship programs and personalized medicine approaches is enhancing clinical decision-making. The growing prevalence of comorbidities such as diabetes and obesity is increasing patient susceptibility, driving demand for effective ABSSSI treatments. Advances in drug delivery systems, including topical and long-acting formulations, are improving patient compliance. As healthcare systems combat resistant pathogens, the ABSSSI treatment market will continue to innovate, delivering advanced therapies that address unmet clinical needs.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Infection Type

• Community-Acquired ABSSSI
• Hospital-Acquired ABSSSI

By Drug Class

• Glycopeptides/Lipoglycopeptides
• Oxazolidinones
• Beta-lactams
• Lipopeptide
• Tetracyclines
• Other Drug Classes

By Route of Administration

• Parenteral
• Oral
• Topical

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• List of Companies Profiled in the report
• AbbVie, Basilea Pharmaceutica, Cipher Pharmaceuticals, Endo Pharmaceuticals, Glenmark Pharmaceuticals, Melinta Therapeutics, Menarini Group, Merck, Nabriva Therapeutics, Paratek Pharmaceuticals, Pfizer, Sandoz

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Infection Type
  • 3.7.2 Market Attractiveness Analysis By Drug Class
  • 3.7.3 Market Attractiveness Analysis By Route of Administration
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT MARKET ANALYSIS BY INFECTION TYPE

• 5.1. Overview By Infection Type
• 5.2. Historical and Forecast Data Analysis By Infection Type
• 5.3. Community-acquired ABSSSI Historic and Forecast Sales By Regions
• 5.4. Hospital-acquired ABSSSI Historic and Forecast Sales By Regions

6. GLOBAL ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT MARKET ANALYSIS BY DRUG CLASS

• 6.1. Overview By Drug Class
• 6.2. Historical and Forecast Data Analysis By Drug Class
• 6.3. Glycopeptides/Lipoglycopeptides Historic and Forecast Sales By Regions
• 6.4. Oxazolidinones Historic and Forecast Sales By Regions
• 6.5. Beta-lactams Historic and Forecast Sales By Regions
• 6.6. Lipopeptide Historic and Forecast Sales By Regions
• 6.7. Tetracyclines Historic and Forecast Sales By Regions
• 6.8. Other Drug Classes Historic and Forecast Sales By Regions

7. GLOBAL ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1. Overview By Route of Administration
• 7.2. Historical and Forecast Data Analysis By Route of Administration
• 7.3. Parenteral Historic and Forecast Sales By Regions
• 7.4. Oral Historic and Forecast Sales By Regions
• 7.5. Topical Historic and Forecast Sales By Regions

8. GLOBAL ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data Analysis By Distribution Channel
• 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
• 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
• 8.5. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT COMPANIES

• 10.1. Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) TREATMENT INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. AbbVie
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Basilea Pharmaceutica
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Cipher Pharmaceuticals
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Endo Pharmaceuticals
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Glenmark Pharmaceuticals
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Melinta Therapeutics
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Menarini Group
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Merck
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Nabriva Therapeutics
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Paratek Pharmaceuticals
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Pfizer
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Sandoz
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Infection Type (USD MN)
• Community-acquired ABSSSI Market Sales By Geography (USD MN)
• Hospital-acquired ABSSSI Market Sales By Geography (USD MN)
• Analysis By Drug Class (USD MN)
• Glycopeptides/Lipoglycopeptides Market Sales By Geography (USD MN)
• Oxazolidinones Market Sales By Geography (USD MN)
• Beta-lactams Market Sales By Geography (USD MN)
• Lipopeptide Market Sales By Geography (USD MN)
• Tetracyclines Market Sales By Geography (USD MN)
• Other Drug Classes Market Sales By Geography (USD MN)
• Analysis By Route of Administration (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Oral Market Sales By Geography (USD MN)
• Topical Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Report
• Market Research Process
• Market Research Methodology
• Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Infection Type
• Market Attractiveness Analysis By Drug Class
• Market Attractiveness Analysis By Route of Administration
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Infection Type (USD MN)
• Community-acquired ABSSSI Market Sales By Geography (USD MN)
• Hospital-acquired ABSSSI Market Sales By Geography (USD MN)
• Global Market Analysis By Drug Class (USD MN)
• Glycopeptides/Lipoglycopeptides Market Sales By Geography (USD MN)
• Oxazolidinones Market Sales By Geography (USD MN)
• Beta-lactams Market Sales By Geography (USD MN)
• Lipopeptide Market Sales By Geography (USD MN)
• Tetracyclines Market Sales By Geography (USD MN)
• Other Drug Classes Market Sales By Geography (USD MN)
• Global Market Analysis By Route of Administration (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Oral Market Sales By Geography (USD MN)
• Topical Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital Pharmacies Market Sales By Geography (USD MN)
• Retail Pharmacies Market Sales By Geography (USD MN)
• Online Pharmacies Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.